Earnings Alerts

Analyzing Jiangsu Hengli Highpressure Oil Cylinder (601100) Earnings: 1Q Net Income Reveals Promising Buy Indications

  • Jiangsu Hengli reported a net income of 601.9 million yuan for the first quarter.
  • The company’s revenue for the same period was 2.36 billion yuan.
  • The market has a positive outlook for the company with 27 buy ratings.
  • There are mixed sentiments as well with 6 hold ratings.
  • Only 1 analyst has issued a sell rating.

A look at Jiangsu Hengli Highpressure Oil Cylinder Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth4
Resilience5
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

In analyzing the long-term outlook for Jiangsu Hengli Highpressure Oil Cylinder, a comprehensive evaluation utilizing Smartkarma Smart Scores reveals a promising future. With commendable scores in Growth and Resilience, the company showcases a strong potential for expansion and a solid ability to withstand market fluctuations. Additionally, the Momentum score indicates positive momentum in the company’s performance, further bolstering its outlook. While the Value score could see improvement, the overall outlook remains optimistic based on the favorable ratings across various factors.

Jiangsu Hengli Hydraulic Co Ltd, specializing in the development, manufacturing, and sale of high-pressure oil cylinders and hydraulic systems, is positioned for long-term success. The company’s product portfolio, including fuel tanks and non-standard cylinders for heavy equipment, underscores its niche expertise in serving industrial needs. With competitive scores in Dividend, Growth, Resilience, and Momentum, Jiangsu Hengli Highpressure Oil Cylinder demonstrates a robust foundation for sustained growth and resilience in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars